TY - BOOK AU - Sun,Haochen AU - Sunder,Madhavi TI - Intellectual property, COVID-19, and the next pandemic: diagnosing problems, developing cures SN - 9781009282406 (ebook) AV - K1401 .I5549 2024 U1 - 346.04/86 23/eng/20231023 PY - 2024/// CY - Cambridge , United Kingdom ; New York, NY PB - Cambridge University Press KW - Intellectual property (International law) KW - Vaccines KW - Patents KW - COVID-19 (Disease) KW - Law and legislation KW - COVID-19 Pandemic, 2020- KW - Public health laws, Inernational KW - Epidemics KW - Health aspects N1 - Title from publisher's bibliographic system (viewed on 17 Dec 2024); Peter Lee, New and heightened public-private quid pro quos : leveraging public support to enhance private technical disclosure -- Lawrence O. Gostin, Global medical war chest -- Laura G. Pedraza-Fariña, COVID-19 and boundary-crossing collaboration -- Matthew M. Kavanagh and Renu Singh, Legal paradigms and the politics of global COVID-19 vaccine access -- William Fisher, Ruth Okediji, and Padmashree Gehl Sampath, Fostering production of pharmaceutical products in developing countries -- Haochen Sun, Patent Philanthropy -- Cynthia M. Ho, Beyond traditional IP : addressing regulatory barriers -- Calvin WL Ho, Capability approach to developing global health initiatives for equitable access to vaccines -- Sapna Kumar & Ana Santos Rutschman, Planning for pandemic and epidemic-related scarcity of medicines related scarcity of medicines -- Jayashree Watal, Improving global governance of pandemic response : lessons from COVID-19 -- David S. Levine & Joshua D. Sarnoff, Compelling trade secret sharing -- Jorge L. Contreras, voluntary intellectual property pledges and COVID-19 -- Peter K. Yu, China, The TRIPS waiver and the global pandemic response -- Olufunmilayo Arewa, COVID-19 exclusion, policy contagion, and colonial hangover in Africa -- Kenneth C. Shadlen, Technology transfer for production of COVID-19 vaccines in Latin America; Open Access N2 - This volume assesses the role of intellectual property in pandemic times through lessons learned from COVID-19. Authored by an international roster of experts, chapters diagnose causes for the inequitable distribution of lifesaving COVID-19 vaccines and offer concrete suggestions for reform. From delinking vaccine development from monopoly rights in technology, to enhanced legal requirements under national and international law for sharing publicly funded technologies, to requiring funding from rich nations to former colonies to build local vaccine manufacturing capacity in low and middle-income countries (including those in Africa), this work highlights timely IP reforms that prepare us for the next pandemic. This title is also available as Open Access on Cambridge Core UR - https://doi.org/10.1017/9781009282406 ER -